A systematic review of obesity prevalence and its contributing factors among individuals diagnosed with schizophrenia

• by Jianmei Long, Bo Yang, Qiong Zheng

• April 27, 2026

Addressing Tamoxifen-Associated Weight Gain: Lifestyle and Pharmacotherapy Options

Tamoxifen is commonly prescribed in hormone receptor-positive breast cancer but also associated with weight gain, which can complicate survivorship care. This narrative review summarizes evidence on tamoxifen-associated weight gain and outlines pharmacologic weight management options in this population.

• by Latonya Fore-Williams, Michele Distler

• May 13, 2026

• 13 min

Association of CTI and its obesity-related derivatives with incident depression among middle-aged and older adults across CKM stages 0-4: a nationwide prospective cohort study and external clinical validation

• by Rui Zhang, Bin Yang, Na-Na Pan, Yi An, Qing Yu

• May 20, 2026

The interplay of maturity-onset diabetes of the young, obesity, uncontrolled hypertension, and cannabinoid hyperemesis in the progression to end-stage renal disease: a case report

• by Neguemadji Ngardig Ngaba, Victoria Lovallo, Anna ONeil, Xegfred Lou T. Quidet, Michael Asare, Henry Nabeta, Shagun Thakur, Riddick Osei Agyemang, Rayan Alataa, Fouad Kaddour Hocine, Karla Garcia Rodriguez, Abel Akanyijuka, Dennis Ansah, Akua Amoa, Oserefuamen Okobi, Shazia Khan, Ruchita Kodakandla, Sahil Dudhat, Shrushti Tanna, Del Orbe Eduardo, Muhammad Saleem Akhter, Rabih Nasr, Kalpana Uday, Khaja Misbahuddin

• May 1, 2026